Endurance Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$3K Hold
130
﹤0.01% 583
2023
Q1
$3K Hold
130
﹤0.01% 586
2022
Q4
$3K Hold
130
﹤0.01% 571
2022
Q3
$3K Hold
130
﹤0.01% 544
2022
Q2
$4K Sell
130
-371
-74% -$15.8K ﹤0.01% 548
2022
Q1
$36K Hold
501
﹤0.01% 385
2021
Q4
$46K Hold
501
﹤0.01% 362
2021
Q3
$64K Hold
501
0.01% 328
2021
Q2
$83K Hold
501
0.01% 306
2021
Q1
$91K Buy
501
+331
+195% +$76.8K 0.01% 292
2020
Q4
$34K Hold
170
﹤0.01% 366
2020
Q3
$37K Buy
170
+40
+31% +$8.47K 0.01% 342
2020
Q2
$25K Hold
130
﹤0.01% 378
2020
Q1
$20K Hold
130
﹤0.01% 368
2019
Q4
$11K Hold
130
﹤0.01% 416
2019
Q3
$9K Buy
+130
New +$8.56K ﹤0.01% 428

Other funds holding TDOC

Endurance Wealth Management's TDOC Position: Q2 2023 in Review

Endurance Wealth Management held its Teladoc Health (TDOC) position steady in Q2 2023 at 130 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Endurance Wealth Management first reported a position in TDOC in Q3 2019 and has held it in 16 quarters since. The position peaked at $91K in Q1 2021. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Endurance Wealth Management held 130 shares of Teladoc Health worth $3K as of Q2 2023.
  • Endurance Wealth Management left its Teladoc Health share count unchanged in Q2 2023.
  • Teladoc Health made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #583 holding.
  • Endurance Wealth Management first reported a position in Teladoc Health in Q3 2019 and has held it in 16 quarters since.
  • Endurance Wealth Management's Teladoc Health position peaked at $91K in Q1 2021.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.